Can I Have My Coffee and Drink It? A Systematic Review and Meta-analysis to Determine Whether Habitual Caffeine Consumption Affects the Ergogenic Effect of Caffeine

Carregando...
Imagem de Miniatura
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ADIS INT LTD
Citação
SPORTS MEDICINE, v.52, n.9, p.2209-2220, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective The aim was to quantify the proportion of the literature on caffeine supplementation that reports habitual caffeine consumption, and determine the influence of habitual consumption on the acute exercise response to caffeine supplementation, using a systematic review and meta-analytic approach. Methods Three databases were searched, and articles screened according to inclusion/exclusion criteria. Three-level meta-analyses and meta-regression models were used to investigate the influence of habitual caffeine consumption on caffeine's overall ergogenic effect and within different exercise types (endurance, power, strength), in men and women, and in trained and untrained individuals. Sub-analyses were performed according to the following: acute relative dose (< 3, 3-6, > 6 mg/kg body mass [BM]); whether the acute caffeine dose provided was lower or higher than the mean daily caffeine dose; and the caffeine withdrawal period prior to the intervention (< 24, 24-48, > 48 h). Results Sixty caffeine studies included sufficient information on habitual consumption to be included in the meta-analysis. A positive overall effect of caffeine was shown in comparison to placebo (standard mean difference [SMD] = 0.25, 95% confidence interval [CI] 0.20-0.30; p < 0.001) with no influence of relative habitual caffeine consumption (p = 0.59). Subgroup analyses showed a significant ergogenic effect when the caffeine dose was < 3 mg/kg BM (SMD = 0.26, 95% CI 0.12-0.40; p = 0.003) and 3-6 mg/kg BM (SMD = 0.26, 95% CI 0.21-0.32; p < 0.0001), but not > 6 mg/kg BM (SMD = 0.11, 95% CI - 0.07 to 0.30; p = 0.23); when the dose was both higher (SMD = 0.26, 95% CI 0.20-0.31; p < 0.001) and lower (SMD = 0.21, 95% CI 0.06-0.36; p = 0.006) than the habitual caffeine dose; and when withdrawal was < 24 h, 24-48 h, and > 48 h. Caffeine was effective for endurance, power, and strength exercise, with no influence (all p >= 0.23) of relative habitual caffeine consumption within exercise types. Habitual caffeine consumption did not modify the ergogenic effect of caffeine in male, female, trained or untrained individuals. Conclusion Habitual caffeine consumption does not appear to influence the acute ergogenic effect of caffeine.
Palavras-chave
Referências
  1. Aguilar-Navarro M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020286
  2. Andre, 2015, INT J EXERC SCI, V8, P5
  3. Areta JL, 2017, J APPL PHYSIOL, V123, P1414, DOI 10.1152/japplphysiol.00489.2017
  4. Astorino TA, 2008, EUR J APPL PHYSIOL, V102, P127, DOI 10.1007/s00421-007-0557-x
  5. Astorino TA, 2012, PHYSIOL BEHAV, V106, P211, DOI 10.1016/j.physbeh.2012.02.006
  6. Astorino TA, 2011, J STRENGTH COND RES, V25, P1752, DOI 10.1519/JSC.0b013e3181ddf6db
  7. BANGSBO J, 1992, J APPL PHYSIOL, V72, P1297, DOI 10.1063/1.351736
  8. Beaumont R, 2017, J SPORT SCI, V35, P1920, DOI 10.1080/02640414.2016.1241421
  9. Beaumont RE, 2017, J SCI MED SPORT, V20, P1024, DOI 10.1016/j.jsams.2017.03.017
  10. Bell DG, 2002, J APPL PHYSIOL, V93, P1227, DOI 10.1152/japplphysiol.00187.2002
  11. BOULENGER JP, 1983, LIFE SCI, V32, P1135, DOI 10.1016/0024-3205(83)90119-4
  12. Burke Benjamin I., 2021, Nutrients, V13, P2496, DOI 10.3390/nu13082496
  13. Clarke ND, 2021, INT J SPORT NUTR EXE, V31, P13, DOI 10.1123/ijsnem.2020-0204
  14. Davis J. K., 2012, Journal of Caffeine Research, V2, P31, DOI 10.1089/jcr.2012.0005
  15. Davis JM, 2003, AM J PHYSIOL-REG I, V284, pR399, DOI 10.1152/ajpregu.00386.2002
  16. Desbrow B, 2007, FOOD CHEM TOXICOL, V45, P1588, DOI 10.1016/j.fct.2007.02.020
  17. Desbrow B, 2012, J FOOD COMPOS ANAL, V28, P114, DOI 10.1016/j.jfca.2012.09.001
  18. Desbrow B, 2012, J SPORT SCI, V30, P115, DOI 10.1080/02640414.2011.632431
  19. DODD SL, 1991, EUR J APPL PHYSIOL O, V62, P424, DOI 10.1007/BF00626615
  20. Doherty M, 2004, J SPORT SCI, V22, P637, DOI 10.1080/02640410310001655741
  21. Doherty M, 1998, INT J SPORT NUTR, V8, P95, DOI 10.1123/ijsn.8.2.95
  22. Duncan MJ, 2019, EUR J SPORT SCI, V19, P103, DOI 10.1080/17461391.2018.1508505
  23. Eckerson JM, 2013, J STRENGTH COND RES, V27, P2248, DOI [10.1519/JSC.0b013e31827e14f2, 10.1519/JSC.0b013e31827e14f2.]
  24. Ellis M, 2019, INT J SPORT PHYSIOL, V14, P569, DOI 10.1123/ijspp.2018-0536
  25. Evans M, 2018, INT J SPORT NUTR EXE, V28, P221, DOI 10.1123/ijsnem.2017-0217
  26. Ferreira TT, 2021, CRIT REV FOOD SCI, V61, P2587, DOI 10.1080/10408398.2020.1781051
  27. Filip A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041087
  28. Filip-Stachnik A, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-021-00448-y
  29. Filip-Stachnik A, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-021-00421-9
  30. FLINN S, 1990, INT J SPORTS MED, V11, P188, DOI 10.1055/s-2007-1024789
  31. Foskett A, 2009, INT J SPORT NUTR EXE, V19, P410, DOI 10.1123/ijsnem.19.4.410
  32. Ganio MS, 2011, PHYSIOL BEHAV, V102, P429, DOI 10.1016/j.physbeh.2010.12.005
  33. Glaister M, 2008, MED SCI SPORT EXER, V40, P1835, DOI 10.1249/MSS.0b013e31817a8ad2
  34. Glaister M, 2015, EUR J SPORT SCI, V15, P400, DOI 10.1080/17461391.2014.962619
  35. Goncalves LD, 2017, J APPL PHYSIOL, V123, P213, DOI 10.1152/japplphysiol.00260.2017
  36. GRAHAM TE, 1995, J APPL PHYSIOL, V78, P867, DOI 10.1152/jappl.1995.78.3.867
  37. Graham-Paulson T, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070393
  38. Graham-Paulson TS, 2016, INT J SPORT PHYSIOL, V11, P214, DOI 10.1123/ijspp.2015-0073
  39. Grgic J, 2021, EUR J SPORT SCI, V21, P1165, DOI 10.1080/17461391.2020.1817155
  40. Grgic J, 2020, J INT SOC SPORT NUTR, V17, DOI 10.1186/s12970-020-00349-6
  41. Grgic J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030741
  42. Grgic J, 2020, BRIT J SPORT MED, V54, P681, DOI 10.1136/bjsports-2018-100278
  43. Grgic J, 2018, EUR J SPORT SCI, V18, P219, DOI 10.1080/17461391.2017.1394371
  44. Grgic J, 2017, EUR J SPORT SCI, V17, P1029, DOI 10.1080/17461391.2017.1330362
  45. Guest N, 2018, MED SCI SPORT EXER, V50, P1570, DOI 10.1249/MSS.0000000000001596
  46. Guest NS, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-020-00383-4
  47. Harrer M., 2021, DOING META ANAL R HA
  48. Irwin C, 2011, J SPORT SCI, V29, P509, DOI 10.1080/02640414.2010.541480
  49. Jenkins NT, 2008, INT J SPORT NUTR EXE, V18, P328, DOI 10.1123/ijsnem.18.3.328
  50. Jones Louise, 2021, Nutrients, V13, P3342, DOI 10.3390/nu13103342
  51. Salinero JJ, 2019, RES SPORTS MED, V27, P238, DOI 10.1080/15438627.2018.1552146
  52. Karayigit R, 2021, EFFECTS LOW DOSE CAF
  53. Karayigit R, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010002
  54. Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.005
  55. Khcharem A, 2021, PHARMACOL BIOCHEM BE, V207, DOI 10.1016/j.pbb.2021.173219
  56. Lane SC, 2014, APPL PHYSIOL NUTR ME, V39, P1050, DOI 10.1139/apnm-2013-0336
  57. Lara B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210275
  58. Maughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027
  59. Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5
  60. Norum M, 2020, SCAND J MED SCI SPOR, V30, P2116, DOI 10.1111/sms.13776
  61. Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n71
  62. Painelli VD, 2021, INT J SPORT NUTR EXE, V31, P321, DOI 10.1123/ijsnem.2020-0363
  63. Pataky MW, 2016, SCAND J MED SCI SPOR, V26, P613, DOI 10.1111/sms.12501
  64. Pickering C, 2019, SPORTS MED, V49, P1007, DOI 10.1007/s40279-019-01101-0
  65. Pickering C, 2019, SPORTS MED, V49, P833, DOI 10.1007/s40279-018-0980-7
  66. Pickering C, 2018, SPORTS MED, V48, P7, DOI 10.1007/s40279-017-0776-1
  67. Potgieter S, 2018, INT J SPORT NUTR EXE, V28, P228, DOI 10.1123/ijsnem.2017-0165
  68. Ranchordas MK, 2018, INT J SPORT NUTR EXE, V28, P629, DOI 10.1123/ijsnem.2017-0405
  69. Roelands B, 2011, EUR J APPL PHYSIOL, V111, P3089, DOI 10.1007/s00421-011-1945-9
  70. Sabol F, 2019, INT J SPORT PHYSIOL, V14, P1170, DOI 10.1123/ijspp.2018-0884
  71. Saunders B, 2017, SCAND J MED SCI SPOR, V27, P1240, DOI 10.1111/sms.12793
  72. Saunders B, 2017, BRIT J SPORT MED, V51, P658, DOI 10.1136/bjsports-2016-096396
  73. Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100
  74. Skinner TL, 2019, MED SCI SPORT EXER, V51, P1195, DOI 10.1249/MSS.0000000000001885
  75. Smirmaul BPC, 2017, EUR J APPL PHYSIOL, V117, P27, DOI 10.1007/s00421-016-3496-6
  76. Sokmen B, 2008, J STRENGTH COND RES, V22, P978, DOI 10.1519/JSC.0b013e3181660cec
  77. Southward K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101352
  78. Southward K, 2018, SPORTS MED, V48, P2425, DOI 10.1007/s40279-018-0967-4
  79. Souza DB, 2019, INT J SPORT PHYSIOL, V14, P216, DOI 10.1123/ijspp.2018-0224
  80. Stojanovic E, 2019, APPL PHYSIOL NUTR ME, V44, P849, DOI 10.1139/apnm-2018-0671
  81. Svenningsson P, 1999, J NEUROSCI, V19, P4011
  82. Tomazini F, 2020, PHARMANUTRITION, V12, DOI 10.1016/j.phanu.2020.100181
  83. Trexler ET, 2016, EUR J SPORT SCI, V16, P702, DOI 10.1080/17461391.2015.1085097
  84. Van Soeren MH, 1998, J APPL PHYSIOL, V85, P1493, DOI 10.1152/jappl.1998.85.4.1493
  85. VANSOEREN MH, 1993, J APPL PHYSIOL, V75, P805, DOI 10.1152/jappl.1993.75.2.805
  86. Venier S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040937
  87. Wilk M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020406
  88. Wilk M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081912
  89. Wilk M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071465
  90. Woolf K, 2008, INT J SPORT NUTR EXE, V18, P412, DOI 10.1123/ijsnem.18.4.412
  91. Woolf K, 2009, J STRENGTH COND RES, V23, P1363, DOI 10.1519/JSC.0b013e3181b3393b
  92. Zbinden-Foncea H, 2018, INT J SPORT PHYSIOL, V13, P145, DOI 10.1123/ijspp.2016-0705
  93. Zhang Y, 2019, J CLIN EPIDEMIOL, V111, P94, DOI 10.1016/j.jclinepi.2018.01.013